The ERα-NRF2 Signaling Axis Promotes Bicalutamide Resistance in Prostate Cancer

Investigators performed bioinformatic analysis and immunohistochemical staining on normal and cancerous prostate tissue to evaluate ERα and NRF2 expression and their correlation.